|
⚲
|
| Keyboard |
| GV 2016 LP
✚
|
|
|---|---|
| CIK # | 0001721789 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001721789] | |
| 4 | [0001721789] | |
| SC 13G | [0001721789] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Starco Brands Inc STCB
Class A Common Stock
|
2025-05-15 | Other | 47,980,156 | ||
|
Starco Brands Inc STCB
Class A Common Stock
|
2024-02-15 | Other | 36,300,393 | ||
|
Starco Brands Inc STCB
Class A Common Stock
|
2024-02-14 | Other | 5,675,399 | ||
|
IonQ Inc IONQ
Common Stock
|
2022-04-11 | Sell | 539,257 | $11.16 | 6,018,108 |
|
IonQ Inc IONQ
Common Stock
|
2022-04-11 | Sell | 4,992 | $11.83 | 59,055 |
|
IonQ Inc IONQ
Common Stock
|
2022-04-11 | Other | 2,642,573 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Series A Preferred Stock · derivative
|
2021-02-17 | Conversion | 5,000,000 | ||
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2021-02-17 | Conversion | 321,978 | ||
|
Dianthus Therapeutics Inc /DE/ MGTA
Series B Preferred Stock · derivative
|
2018-06-25 | Conversion | 8,494,864 | ||
|
Dianthus Therapeutics Inc /DE/ MGTA
Common Stock
|
2018-06-25 | Conversion | 3,339,137 | ||
|
Dianthus Therapeutics Inc /DE/ MGTA
Series A Preferred Stock · derivative
|
2018-06-25 | Conversion | 133,400 | ||
|
Arcus Biosciences Inc RCUS
Series B Convertible Preferred Stock · derivative
|
2018-03-19 | Conversion | 3,125,312 | ||
|
Arcus Biosciences Inc RCUS
Common Stock
|
2018-03-19 | Conversion | 3,125,312 | ||
|
ARMO BioSciences Inc ARMO
Series C-1 Convertible Preferred Stock · derivative
|
2018-01-30 | Conversion | 607,350 | ||
|
ARMO BioSciences Inc ARMO
Common Stock
|
2018-01-30 | Conversion | 607,350 | ||
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 451,362 | ||
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 1,540,499 |